ANI Pharmaceuticals Inc (ANIP)
55.86
+0.76
(+1.38%)
USD |
NASDAQ |
Nov 21, 16:00
55.80
-0.06
(-0.11%)
Pre-Market: 08:54
ANI Pharmaceuticals Total Assets (Quarterly): 1.287B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.287B |
| June 30, 2024 | 920.75M |
| March 31, 2024 | 914.52M |
| December 31, 2023 | 904.42M |
| September 30, 2023 | 889.91M |
| June 30, 2023 | 859.34M |
| March 31, 2023 | 765.22M |
| December 31, 2022 | 760.09M |
| September 30, 2022 | 739.11M |
| June 30, 2022 | 751.33M |
| March 31, 2022 | 744.85M |
| December 31, 2021 | 771.60M |
| September 30, 2021 | 470.45M |
| June 30, 2021 | 480.16M |
| March 31, 2021 | 463.84M |
| December 31, 2020 | 461.19M |
| September 30, 2020 | 462.58M |
| June 30, 2020 | 465.39M |
| March 31, 2020 | 482.23M |
| December 31, 2019 | 456.79M |
| September 30, 2019 | 456.78M |
| June 30, 2019 | 446.91M |
| March 31, 2019 | 434.39M |
| December 31, 2018 | 430.60M |
| September 30, 2018 | 439.44M |
| Date | Value |
|---|---|
| June 30, 2018 | 424.18M |
| March 31, 2018 | 418.02M |
| December 31, 2017 | 412.14M |
| September 30, 2017 | 370.47M |
| June 30, 2017 | 359.22M |
| March 31, 2017 | 357.14M |
| December 31, 2016 | 322.86M |
| September 30, 2016 | 319.38M |
| June 30, 2016 | 308.00M |
| March 31, 2016 | 291.59M |
| December 31, 2015 | 285.26M |
| September 30, 2015 | 283.28M |
| June 30, 2015 | 270.12M |
| March 31, 2015 | 265.98M |
| December 31, 2014 | 259.56M |
| September 30, 2014 | 107.64M |
| June 30, 2014 | 95.42M |
| March 31, 2014 | 96.65M |
| December 31, 2013 | 44.50M |
| September 30, 2013 | 43.29M |
| June 30, 2013 | 41.66M |
| March 31, 2013 | 35.36M |
| December 31, 2012 | 38.77M |
| September 30, 2012 | 43.21M |
| June 30, 2012 | 47.29M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
456.79M
Minimum
Dec 2019
1.287B
Maximum
Sep 2024
702.56M
Average
748.09M
Median
Total Assets (Quarterly) Benchmarks
| Windtree Therapeutics Inc | 28.71M |
| Allogene Therapeutics Inc | 589.12M |
| AIM ImmunoTech Inc | 13.59M |
| Protalix BioTherapeutics Inc | 61.56M |
| Armata Pharmaceuticals Inc | 98.24M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 856.58M |
| Shareholders Equity (Quarterly) | 430.80M |
| Debt to Equity Ratio | 1.452 |
| Current Ratio | 2.745 |
| Net Debt Paydown Yield | -5.40% |